SSTR2 and neoplasm: This study demonstrates the increased presence and expression of the somatostatin receptor 2 in pleomorphic adenomas in comparison to the Warthin tumor, thereby explaining the strong tracer-uptake in the DOTATOC PET/CT in a pleomorphic adenoma described in the case study by Laurens et al. tumors with an intensity of SSTR2 expression greater than or equal to 2 were strongly associated with the presence of a pleomorphic adenoma (89.9%, 95% CI 82.2–95.0%).